179 related articles for article (PubMed ID: 29872938)
1. The poly (ADP-ribose) polymerase inhibitor rucaparib suppresses proliferation and serves as an effective radiosensitizer in cervical cancer.
Tang M; Liu Q; Zhou L; Chen L; Yang X; Yu J; Wang Y; Qiu H
Invest New Drugs; 2019 Feb; 37(1):65-75. PubMed ID: 29872938
[TBL] [Abstract][Full Text] [Related]
2. An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.
Nile DL; Rae C; Hyndman IJ; Gaze MN; Mairs RJ
BMC Cancer; 2016 Aug; 16():621. PubMed ID: 27515310
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.
Augustine T; Maitra R; Zhang J; Nayak J; Goel S
Invest New Drugs; 2019 Oct; 37(5):948-960. PubMed ID: 30612311
[TBL] [Abstract][Full Text] [Related]
4. MAPK4 deletion enhances radiation effects and triggers synergistic lethality with simultaneous PARP1 inhibition in cervical cancer.
Tian S; Lou L; Tian M; Lu G; Tian J; Chen X
J Exp Clin Cancer Res; 2020 Jul; 39(1):143. PubMed ID: 32711558
[TBL] [Abstract][Full Text] [Related]
5. Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.
García-Parra J; Dalmases A; Morancho B; Arpí O; Menendez S; Sabbaghi M; Zazo S; Chamizo C; Madoz J; Eroles P; Servitja S; Tusquets I; Yelamos J; Lluch A; Arribas J; Rojo F; Rovira A; Albanell J
Eur J Cancer; 2014 Oct; 50(15):2725-34. PubMed ID: 25128455
[TBL] [Abstract][Full Text] [Related]
6. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
Xiong Y; Li T; Assani G; Ling H; Zhou Q; Zeng Y; Zhou F; Zhou Y
Biomed Pharmacother; 2019 Apr; 112():108602. PubMed ID: 30784916
[TBL] [Abstract][Full Text] [Related]
7. Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo.
Luo J; Zhu W; Tang Y; Cao H; Zhou Y; Ji R; Zhou X; Lu Z; Yang H; Zhang S; Cao J
Radiat Oncol; 2014 Mar; 9():84. PubMed ID: 24666614
[TBL] [Abstract][Full Text] [Related]
8. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
9. CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.
Lee S; Ho JY; Liu JJ; Lee H; Park JY; Baik M; Ko M; Lee SU; Choi YJ; Hur SY
Mol Med; 2019 May; 25(1):23. PubMed ID: 31138113
[TBL] [Abstract][Full Text] [Related]
10. Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block.
Gong XM; Zhang Q; Torossian A; Cao JP; Fu S
Int J Gynecol Cancer; 2012 Jun; 22(5):718-24. PubMed ID: 22552829
[TBL] [Abstract][Full Text] [Related]
11. Rucaparib antagonize multidrug resistance in cervical cancer cells through blocking the function of ABC transporters.
Chen Z; Ling K; Zhu Y; Deng L; Li Y; Liang Z
Gene; 2020 Oct; 759():145000. PubMed ID: 32717310
[TBL] [Abstract][Full Text] [Related]
12. Apatinib, a novel tyrosine kinase inhibitor, suppresses tumor growth in cervical cancer and synergizes with Paclitaxel.
Qiu H; Li J; Liu Q; Tang M; Wang Y
Cell Cycle; 2018; 17(10):1235-1244. PubMed ID: 29886786
[TBL] [Abstract][Full Text] [Related]
13. Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo.
Zhang J
Reprod Sci; 2021 Feb; 28(2):524-531. PubMed ID: 32944878
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation.
Ye Y; Xu W; Zhong W; Li Y; Wang C
Mol Cell Biochem; 2012 Apr; 363(1-2):191-202. PubMed ID: 22147199
[TBL] [Abstract][Full Text] [Related]
15. Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers.
Hastak K; Bhutra S; Parry R; Ford JM
Oncotarget; 2017 Apr; 8(16):26344-26355. PubMed ID: 28412751
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
17. Sinomenine hydrochloride sensitizes cervical cancer cells to ionizing radiation by impairing DNA damage response.
Zhang D; Dong Y; Zhao Y; Zhou C; Qian Y; Hegde ML; Wang H; Han S
Oncol Rep; 2018 Nov; 40(5):2886-2895. PubMed ID: 30226618
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
[TBL] [Abstract][Full Text] [Related]
19. BRD4 Inhibitor AZD5153 Suppresses the Proliferation of Colorectal Cancer Cells and Sensitizes the Anticancer Effect of PARP Inhibitor.
Zhang P; Li R; Xiao H; Liu W; Zeng X; Xie G; Yang W; Shi L; Yin Y; Tao K
Int J Biol Sci; 2019; 15(9):1942-1954. PubMed ID: 31523195
[No Abstract] [Full Text] [Related]
20. MGDG extracted from spinach enhances the cytotoxicity of radiation in pancreatic cancer cells.
Akasaka H; Mizushina Y; Yoshida K; Ejima Y; Mukumoto N; Wang T; Inubushi S; Nakayama M; Wakahara Y; Sasaki R
Radiat Oncol; 2016 Nov; 11(1):153. PubMed ID: 27876069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
